We’re excited to announce that Avi Goldfarb has joined Future Fertility as a member of our esteemed Advisory Board. Avi is a renowned expert in the fields of healthcare AI and marketing, supporting many large global companies with their approaches to the integration of AI into their innovation plans. His expertise will play a key role on our advisory board as we advance our responsible AI solutions and develop clear messaging in the market around the role of AI in clinical care.
Avi holds the prestigious Rotman Chair in Artificial Intelligence and Healthcare and is a Professor of Marketing at the Rotman School of Management, University of Toronto. He also serves as Chief Data Scientist at the Creative Destruction Lab and is a Research Associate at the National Bureau of Economic Research. With his multidisciplinary background, Avi has published numerous academic articles in various fields, including marketing, computing, law, management, medicine, physics, political science, public health, statistics, and economics.
His groundbreaking research on the economics of digital technology and AI has earned him accolades, including the INFORMS Society of Marketing Science Long Term Impact Award for his work on online advertising. From this research, he also co-authored the bestselling books “Prediction Machines: The Simple Economics of Artificial Intelligence” and “Power and Prediction: The Disruptive Economics of Artificial Intelligence”.
“We are honoured to have Avi join our Advisory Board,” said Christy Prada, CEO of Future Fertility. “His unparalleled expertise at the intersection of AI, healthcare, and marketing will be invaluable as we continue to push the boundaries of fertility research and innovation. Avi’s insights and guidance will help us further our mission of providing cutting-edge solutions to enhance fertility outcomes for individuals and couples around the world.”
Avi Goldfarb is equally enthusiastic about joining our team: “I’m excited to be part of the Future Fertility team and contribute to their pioneering efforts in building robust AI models to better understand oocyte quality,” said Avi. “The application of artificial intelligence to healthcare has immense potential to revolutionize the way we approach fertility treatments, and I look forward to collaborating with the team to drive meaningful advancements in this space.”
As Future Fertility continues to pave the way in advancing fertility technology and research, Avi expands our Advisory Board’s experience with deep knowledge of machine learning capabilities in addition to the strong embryology & scientific research experience contributed by Dr. Jim Meriano and Dr. Rita Vassena. We are grateful to have Avi on board and keenly anticipate the invaluable contributions he will make to our organization.
Join our mailing list for dispatches on the future of fertility